Weitong Huang
Shenyang Pharmaceutical University(CN)Australian National University(AU)Academy of Medical Sciences(GB)Union Hospital(CN)Harbin Medical University(CN)Chinese Academy of Sciences(CN)Chinese Academy of Medical Sciences & Peking Union Medical College(CN)Huawei Technologies (China)(CN)Biomed Research Institute(US)ShenZhen People’s Hospital(CN)Shanghai Institute of Materia Medica(CN)Center for Excellence in Molecular Cell Science(CN)ZheJiang Academy of Agricultural Sciences(CN)Second Affiliated Hospital of Harbin Medical University(CN)Institute for Advanced Study(DE)ZheJiang Institute For Food and Drug Control(CN)Viva Biotech (China)(CN)University of Chinese Academy of Sciences(CN)Syngenta (China)(CN)State Key Laboratory of Drug ResearchHuazhong University of Science and Technology(CN)Clemson University(US)Taizhou University(CN)Academia Sinica(TW)
Publications by Year
Research Areas
Glycosylation and Glycoproteins Research, Monoclonal and Polyclonal Antibodies Research, Carbohydrate Chemistry and Synthesis, Chemical Synthesis and Analysis, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → A dual thrombin receptor system for platelet activation(1998)970 cited
- → CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation(2017)756 cited
- → Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa(2000)670 cited
- → Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids(2017)559 cited
- → Role of thrombin signalling in platelets in haemostasis and thrombosis(2001)510 cited
- → Cellular Localization of Membrane-type Serine Protease 1 and Identification of Protease-activated Receptor-2 and Single-chain Urokinase-type Plasminogen Activator as Substrates(2000)436 cited